annual EBIT:
-$719.87M-$2.01B(-155.69%)Summary
- As of today (May 29, 2025), BNTX annual earnings before interest & taxes is -$719.87 million, with the most recent change of -$2.01 billion (-155.69%) on December 31, 2024.
- During the last 3 years, BNTX annual EBIT has fallen by -$18.38 billion (-104.08%).
- BNTX annual EBIT is now -104.08% below its all-time high of $17.66 billion, reached on December 31, 2021.
Performance
BNTX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$432.99M-$751.71M(-235.85%)Summary
- As of today (May 29, 2025), BNTX quarterly earnings before interest & taxes is -$432.99 million, with the most recent change of -$751.71 million (-235.85%) on March 1, 2025.
- Over the past year, BNTX quarterly EBIT has dropped by -$77.70 million (-21.87%).
- BNTX quarterly EBIT is now -107.68% below its all-time high of $5.64 billion, reached on March 31, 2022.
Performance
BNTX quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$790.72M-$77.70M(-10.90%)Summary
- As of today (May 29, 2025), BNTX TTM earnings before interest & taxes is -$790.72 million, with the most recent change of -$77.70 million (-10.90%) on March 1, 2025.
- Over the past year, BNTX TTM EBIT has dropped by -$955.00 million (-581.33%).
- BNTX TTM EBIT is now -103.72% below its all-time high of $21.24 billion, reached on March 31, 2022.
Performance
BNTX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
BNTX EBIT Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -155.7% | -21.9% | -581.3% |
3 y3 years | -104.1% | -107.7% | -103.7% |
5 y5 years | -261.9% | -640.3% | -277.9% |
BNTX EBIT Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -104.1% | at low | -107.7% | +49.6% | -103.7% | at low |
5 y | 5-year | -104.1% | at low | -107.7% | +49.6% | -103.7% | at low |
alltime | all time | -104.1% | at low | -107.7% | +49.6% | -103.7% | at low |
BNTX EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | -$432.99M(-235.9%) | -$790.72M(+10.9%) |
Dec 2024 | -$719.87M(-155.7%) | $318.72M(+73.8%) | -$713.02M(+127.2%) |
Sep 2024 | - | $183.34M(-121.3%) | -$313.87M(+26.8%) |
Jun 2024 | - | -$859.79M(+142.0%) | -$247.44M(-250.6%) |
Mar 2024 | - | -$355.29M(-149.5%) | $164.28M(-87.5%) |
Dec 2023 | $1.29B(-90.6%) | $717.87M(+187.4%) | $1.31B(-65.9%) |
Sep 2023 | - | $249.77M(-155.7%) | $3.84B(-36.6%) |
Jun 2023 | - | -$448.06M(-156.6%) | $6.06B(-29.2%) |
Mar 2023 | - | $791.24M(-75.6%) | $8.55B(-36.2%) |
Dec 2022 | $13.68B(-22.5%) | $3.25B(+31.6%) | $13.40B(-13.0%) |
Sep 2022 | - | $2.47B(+20.5%) | $15.41B(-16.5%) |
Jun 2022 | - | $2.05B(-63.7%) | $18.44B(-13.2%) |
Mar 2022 | - | $5.64B(+7.3%) | $21.24B(+20.8%) |
Dec 2021 | $17.66B | $5.25B(-4.6%) | $17.59B(+39.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2021 | - | $5.50B(+13.5%) | $12.58B(+84.1%) |
Jun 2021 | - | $4.85B(+144.9%) | $6.83B(+262.6%) |
Mar 2021 | - | $1.98B(+705.3%) | $1.88B(-1325.1%) |
Dec 2020 | -$164.22M(-17.4%) | $245.85M(-201.6%) | -$153.82M(-66.9%) |
Sep 2020 | - | -$242.07M(+144.2%) | -$464.22M(+82.0%) |
Jun 2020 | - | -$99.12M(+69.5%) | -$255.05M(+21.9%) |
Mar 2020 | - | -$58.49M(-9.4%) | -$209.23M(+6.5%) |
Dec 2019 | -$198.93M(+266.7%) | -$64.55M(+96.3%) | -$196.47M(+47.6%) |
Sep 2019 | - | -$32.89M(-38.3%) | -$133.11M(+6.5%) |
Jun 2019 | - | -$53.30M(+16.5%) | -$124.97M(+74.4%) |
Mar 2019 | - | -$45.73M(+3738.9%) | -$71.67M(+176.3%) |
Dec 2018 | -$54.25M(-43.8%) | -$1.19M(-95.2%) | -$25.94M(+4.8%) |
Sep 2018 | - | -$24.75M | -$24.75M |
Dec 2017 | -$96.52M | - | - |
FAQ
- What is BioNTech SE annual earnings before interest & taxes?
- What is the all time high annual EBIT for BioNTech SE?
- What is BioNTech SE annual EBIT year-on-year change?
- What is BioNTech SE quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for BioNTech SE?
- What is BioNTech SE quarterly EBIT year-on-year change?
- What is BioNTech SE TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for BioNTech SE?
- What is BioNTech SE TTM EBIT year-on-year change?
What is BioNTech SE annual earnings before interest & taxes?
The current annual EBIT of BNTX is -$719.87M
What is the all time high annual EBIT for BioNTech SE?
BioNTech SE all-time high annual earnings before interest & taxes is $17.66B
What is BioNTech SE annual EBIT year-on-year change?
Over the past year, BNTX annual earnings before interest & taxes has changed by -$2.01B (-155.69%)
What is BioNTech SE quarterly earnings before interest & taxes?
The current quarterly EBIT of BNTX is -$432.99M
What is the all time high quarterly EBIT for BioNTech SE?
BioNTech SE all-time high quarterly earnings before interest & taxes is $5.64B
What is BioNTech SE quarterly EBIT year-on-year change?
Over the past year, BNTX quarterly earnings before interest & taxes has changed by -$77.70M (-21.87%)
What is BioNTech SE TTM earnings before interest & taxes?
The current TTM EBIT of BNTX is -$790.72M
What is the all time high TTM EBIT for BioNTech SE?
BioNTech SE all-time high TTM earnings before interest & taxes is $21.24B
What is BioNTech SE TTM EBIT year-on-year change?
Over the past year, BNTX TTM earnings before interest & taxes has changed by -$955.00M (-581.33%)